Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery

MLA

Mehrdad Hashemi, et al. “Advances in RNAi Therapies for Gastric Cancer: Targeting Drug Resistance and Nanoscale Delivery.” Biomedicine & Pharmacotherapy, vol. 169, no. 115927-, Dec. 2023. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115927.

APA

Mehrdad Hashemi, Rezvaneh Aparviz, Marzie Beickzade, Mahshid Deldar Abad Paskeh, Simin Khorsand Kheirabad, Zeinab Khazaei Koohpar, Amir Moravej, Hossein Dehghani, Hamidreza Saebfar, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari, & Saeed Samarghandian. (2023). Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery. Biomedicine & Pharmacotherapy, 169(115927-). https://doi.org/10.1016/j.biopha.2023.115927

Chicago

Mehrdad Hashemi, Rezvaneh Aparviz, Marzie Beickzade, Mahshid Deldar Abad Paskeh, Simin Khorsand Kheirabad, Zeinab Khazaei Koohpar, Amir Moravej, et al. 2023. “Advances in RNAi Therapies for Gastric Cancer: Targeting Drug Resistance and Nanoscale Delivery.” Biomedicine & Pharmacotherapy 169 (115927-). doi:10.1016/j.biopha.2023.115927.